Furthermore, the activation of reactive astrocytes through astrocyte-specific Nrf2 expression has been shown to decrease amyloid deposits and phosphorylated tau levels, ameliorating cognitive impairments in both APP/PS1 and Thy1-hTau P301S mouse models (Jiwaji et al., 2022). Here, MAPT is linked to Cognitive impairment.